COLOMBO: Glaxosmithkline Consumer Healthcare is currently trading at Rs. 5755.20, up by 24.40 points or 0.43% from its previous closing of Rs. 5730.80 on the BSE.
The scrip opened at Rs. 5410.00 and has touched a high and low of Rs. 5755.20 and Rs. 5400.00 respectively. So far 94 shares were traded on the counter. The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 6800.00 on 23-Dec-2015 and a 52 week low of Rs. 5366.50 on 02-Mar-2016.
Last one week high and low of the scrip stood at Rs. 6020.20 and Rs. 5690.00 respectively. The current market cap of the company is Rs. 24203.80 crore. The promoters holding in the company stood at 72.46%, while institutions and non-institutions held 12.99% and 14.56% respectively.
GlaxoSmithkline Consumer Healthcare has reported 16.62% fall in its net profit at Rs 183.72 crore for the quarter under review as compared to Rs 220.34 crore for the same quarter in the previous year. Total income of the company decreased marginally by 0.82% at Rs 1250.58 crore for the quarter under review as compared Rs 1260.95 crore for the corresponding quarter previous year.
GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
